Projected Growth of 6.37% CAGR in the Hereditary Angioedema Market from 2023 to 2033

Projected Growth of 6.37% CAGR in the Hereditary Angioedema Market from 2023 to 2033

Hereditary Angioedema Market

According to IMARC Group, The hereditary angioedema market is projected to grow at a CAGR of 6.37% during the forecast 2023-2033.

BROOKLYN, NY, USA, July 13, 2023/ — The newly published report by IMARC Group, titled ”Hereditary Angioedema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the hereditary angioedema market size. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the seven major markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced by industry players.

How big is the market for hereditary angioedema?

The hereditary angioedema market is anticipated to grow at a CAGR of 6.37% during 2023-2033.

Request for a Sample Report:

What is hereditary angioedema?

Hereditary Angioedema, or HAE, is a relatively rare genetic condition resulting from a dysfunctional or missing C1-inhibitor protein. The disorder is inherited in an autosomal dominant pattern, meaning a single mutated gene copy in each cell is sufficient to trigger the condition. It manifests as repeated episodes of sudden, severe subcutaneous and submucosal swelling in the face, hands, airways, intestinal tract, trachea, larynx, or tongue, all without the presentation of urticarial lesions. HAE affects the blood vessels, causing extreme pain, nausea, vomiting, fatigue, diarrhea, muscle pain, tingling, headache, abdominal discomfort, hoarseness, and mood fluctuations. The condition also results in fluid leakage from blood vessels into body tissues. HAE impacts approximately 1 in 50,000 individuals and demonstrates no ethnic variation in occurrence. As with other rare conditions, diagnosis often experiences delays, resulting in patients not receiving the necessary treatment in a timely manner.

Explore the Full Report with Table of Contents:

What are the key drivers and trends in the hereditary angioedema market?

The hereditary angioedema market is currently experiencing significant growth, fueled by notable advancements in the comprehension of the mechanisms underlying angioedema. This deeper understanding has paved the way for the creation of contemporary drugs that are not only safe but also highly efficient in treating the condition. The development and refinement of these modern pharmaceutical solutions have thus acted as a significant driver of growth within the market. Moreover, the heightened availability of superior diagnostic tools on a global scale has positively impacted the market. These advanced tools offer more precise and timely diagnoses, enabling healthcare providers to initiate appropriate treatment regimens earlier and improve patient outcomes. Additionally, improvements in the timelines for drug development have also favorably influenced the market. The reduction in development timelines, consequently, contributes to the efficient operation of the market, ensuring a steady supply of necessary medication to meet growing demand, and thereby positively impacting overall market growth.

What is included in the report segmentation?

The report covers the following aspects:

Report Period:

Base Year: 2022
Historical Period: 2017-2022
Market Forecast: 2023-2033

Countries Included:

United States
United Kingdom

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario
Historical, current, and future performance of the hereditary angioedema market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the hereditary angioedema market
Reimbursement scenario in the market
In-market and pipeline drugs

In-Market Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Regulatory Status

Ask an Analyst for Report Customization with Table of Contents:

How This Report Can Help You:

The report on hereditary angioedema market presents a comprehensive overview and analysis of the epidemiology and market for this condition in the seven major markets (7MM): the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.

With insights into both current and emerging therapies in the 7MM, this report offers valuable information for businesses seeking to understand trends and opportunities within the hereditary angioedema market.

The hereditary angioedema market report covers historical and forecasted market data, including epidemiology scenario, providing a reliable and informative resource for developing effective business strategies in 7MM.

Our report on the hereditary angioedema market can help businesses stay abreast of the trends and drivers, gain a competitive edge and drive success.

Browse Our Latest Healthcare Research Report:

Female Infertility Market Report 2023-2033:

Skin Neoplasms Market Report 2023-2033:

B Cell Chronic Lymphocytic Leukemia Market Report 2023-2033:

Nocturnal Enuresis Market Report 2023-2033:

Key Questions Answered in this Report:

How has the hereditary angioedema market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the hereditary angioedema market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the hereditary angioedema market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?

About Us: –

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Elena Anderson
IMARC Services Private Limited
+ 1 631 791 1145
email us here

Article originally published on as Projected Growth of 6.37% CAGR in the Hereditary Angioedema Market from 2023 to 2033

The post Projected Growth of 6.37% CAGR in the Hereditary Angioedema Market from 2023 to 2033 first appeared on Social Gov.

originally published at Business - Social Gov